Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Rehabilitation and Quality of Life in Residential Units for People With Longer Term Mental Health Problems
Brief Summary: The study design is that of a cluster randomised controlled trial

The aims of the study were: 1) to assess the quality of care of the residential units for people with long-term mental disorders; 2) to design a training intervention for the staff of the units in the intervention group; 3) to assess the effectiveness of the intervention 4 and 8 months after it ended.

The main outcome variable was level of activity of the users. Secondary outcome variables were the QuIRC dimensions.

The selection of the sample was by residential units for people with long-term mental disorders.

The inclusion criteria were all the middle and high-support residential units in Portugal. Units that had only one type of service users (e.g., mental retardation, dementia) were excluded.

The quality of care of the units was assessed with the QuIRC filled on line by the managers of the units and validated with Service Users Interview Schedule, a face-to-face interview with the users (users that could not give informed consent or collaborate in the interview were excluded).


Options:
A: Arm Label: GSK257049 [5-17M] Group; Type: EXPERIMENTAL; Interventions: Biological: Malaria Vaccine 257049, Biological: Meningococcal C Conjugate Vaccine | Arm Label: GSK257049 [6-12W] Group; Type: EXPERIMENTAL; Interventions: Biological: Malaria Vaccine 257049, Biological: Meningococcal C Conjugate Vaccine, Biological: TritanrixHepB/Hib, Biological: Polio Sabin Oral Polio Vaccine (GSK) | Arm Label: VeroRab Comparator [5-17M] Group; Type: ACTIVE_COMPARATOR; Interventions: Biological: Meningococcal C Conjugate Vaccine, Biological: Cell-culture rabies vaccine | Arm Label: Menjugate Comparator [6-12W] Group; Type: EXPERIMENTAL; Interventions: Biological: Meningococcal C Conjugate Vaccine, Biological: TritanrixHepB/Hib, Biological: Polio Sabin Oral Polio Vaccine (GSK) | Intervention Type: BIOLOGICAL; Name: Malaria Vaccine 257049; Assigned to Arm(s): GSK257049 [5-17M] Group, GSK257049 [6-12W] Group | Intervention Type: BIOLOGICAL; Name: Meningococcal C Conjugate Vaccine; Assigned to Arm(s): GSK257049 [5-17M] Group, GSK257049 [6-12W] Group, Menjugate Comparator [6-12W] Group, VeroRab Comparator [5-17M] Group | Intervention Type: BIOLOGICAL; Name: Cell-culture rabies vaccine; Assigned to Arm(s): VeroRab Comparator [5-17M] Group | Intervention Type: BIOLOGICAL; Name: TritanrixHepB/Hib; Assigned to Arm(s): GSK257049 [6-12W] Group, Menjugate Comparator [6-12W] Group | Intervention Type: BIOLOGICAL; Name: Polio Sabin Oral Polio Vaccine (GSK); Assigned to Arm(s): GSK257049 [6-12W] Group, Menjugate Comparator [6-12W] Group
B: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Ninos Sanos Familia Sana | Arm Label: Comparison; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Ninos Sanos Familia Sana | Intervention Type: BEHAVIORAL; Name: Ninos Sanos Familia Sana; Assigned to Arm(s): Comparison, Intervention
C: Arm Label: Training; Type: EXPERIMENTAL; Interventions: Behavioral: Training | Arm Label: No Training; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Training; Assigned to Arm(s): Training
D: Arm Label: Interventional; Type: EXPERIMENTAL; Interventions: Other: Systems-level intervention to promote colon cancer screening | Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Systems-level intervention to promote colon cancer screening; Assigned to Arm(s): Interventional

Answer: C